You have 9 free searches left this month | to do more

vosaroxin

Vosaroxin is a drug used to treat Acute Myeloid Leukemia, Myelodysplastic Syndromes, Leukemia, and other conditions. Vosaroxin is being actively studied in 3 studies and prior, has been studied in 5.

Top SponsorsTop SitesTop Investigators
Sunesis PharmaceuticalsIndiana University Cancer CenterStephen Strickland
M.D. Anderson Cancer CenterVanderbilt-Ingram Cancer CenterVerena Gaidzik
University Hospital, AngersCH Amiens Hopital Sud
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
W
Active, not recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-23
Mar 23, 2022
M
Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-01-13
Jan 13, 2022
V
Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • New Haven, Connecticut
  • +2 more
2021-09-08
Sep 8, 2021
U
Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)
  • Essen, Germany
  • +2 more
2020-10-27
Oct 27, 2020
W
Completed
  • Myelodysplastic Syndrome
  • Vosaroxin
  • New York, New York
    Weill Cornell Medical College
2019-01-24
Jan 24, 2019
S
Completed
  • Leukemia, Lymphocytic, Acute
  • +3 more
  • Vosaroxin
  • Tampa, Florida
  • +4 more
2017-03-28
Mar 28, 2017
S
Completed
  • Leukemia
  • +4 more
  • vosaroxin
  • Phoenix, Arizona
  • +19 more
2017-05-25
May 25, 2017